摘要
目的 探讨影响甲按蝶呤联合米非司酮治疗异位妊娠效果的相关因素.方法 选择2009年1月~2013年6月在我院住院治疗的异位妊娠患者110例,按治疗方法不同分成:MTX+ RU486组50例和MTX组60例两组,对两组患者的治疗效果及副作用进行比较,并用Logistic回归分析影响联合用药治疗效果的因素.结果 MTX+ RU486组治疗异位妊娠的有效率为94.00%,MTX组为81.67%,差异有统计学意义(P<0.05).在治疗成功患者中,MTX+RU486组血β-HCG降至阴性所需时间少于MTX组,差异有统计学意义(P<0.05).两组患者用药后不良反应的发生率差异无统计学意义(P>0.05).Logistic回归分析影响联合用药组治疗效果的唯一因素是β-HCG水平.结论 甲氨蝶呤联合米非司酮治疗异位妊娠,成功率高,疗程短,安全可靠,值得临床推广应用。
Objective To compare the effect and side-reaction of MTX+ RU486 with MTX in treatment of ectopic pregnancy and study the related factors affecting MTX+ RU486 treatment. Methods 110 patients diagnosed as ectopic pregnancy were recruited in this study. According to the two different treatment methods, they were assigned into MTX + RU486 group (50 patients) and MTX group(60 patients ). The effect and side-reaction of the two groups were compared and Logistic model analysis of multiple factors was used to study the prognostic factors of MTX+ RU486 treatment. Results The effective rates in MTX+ RU486 group and MTX group were 94.00% and 81. 67% respectively, the difference was significant(P〈0.05). The time of β-HCG to negative of MTX+ RU486 group were less than MTX group in successful treatment patients, the difference was significant(P〈0.05). The only factor on the effect of MTX+ RU486 group was the level of the β -HCG in Logistic model analysis of multiple factors. Vice-reaction were not signifi- cantly different. Conclusion The methods using MTX+ RU486 to treat ectopic pregnancy has the advantages of high effective rates, short course of treatment, safe and reliable, worthy of clinical application.
出处
《西部医学》
2015年第5期765-767,770,共4页
Medical Journal of West China
关键词
异位妊娠
药物治疗
氨甲蝶呤
米非司酮
影响因素
Ectopic pregnancy
Medical treatment
Methotrexate
Mifeprisfone
Influencing facor